$YBCN
Yong Bai Chao New Retail Corp

2024 Q2 Form 10-K Financial Statement

#000147793224002091 Filed on April 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.400K $8.250K $62.02K
YoY Change -8.03% -24.41%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $9.403K $8.250K $62.02K
YoY Change -49.98% -8.03% -24.41%
Operating Profit -$9.403K -$62.02K
YoY Change -49.98% -24.41%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0%
Pretax Income -$9.403K -$8.250K -$62.02K
YoY Change -49.98% -8.03% -35.54%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.403K -$8.250K -$62.02K
YoY Change -49.98% -8.03% -35.54%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 189.1M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.82K $7.320K $7.320K
YoY Change 271.57% 271.57%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $133.9K $106.7K $106.7K
YoY Change 51.4% 138.92% 138.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $133.9K $106.7K $106.7K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $133.9K $106.7K $106.7K
YoY Change 51.4% 138.93% 138.93%
SHAREHOLDERS EQUITY
Retained Earnings -$3.703M -$3.676M
YoY Change 1.24% 1.72%
Common Stock $195.5K $195.5K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares
Shareholders Equity -$133.9K -$106.7K -$106.7K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$9.403K -$8.250K -$62.02K
YoY Change -49.98% -8.03% -35.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00 $0.00 $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 0.000 0.000 $0.00
Cash From Investing Activities
Cash From Financing Activities 0.000 $0.00
Net Change In Cash 0.000 0.000 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00 $0.00 $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Assets Current
AssetsCurrent
0 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1968 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-62017 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
195496 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3613691 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-44642 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-82046 usd
CY2022 us-gaap Interest Expense
InterestExpense
14167 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14167 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3371271 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001284454
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Address Country
EntityAddressCountry
CN
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189495068 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189120068 shares
CY2022Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-56129
CY2023 dei Entity Registrant Name
EntityRegistrantName
YONG BAI CHAO NEW RETAIL CORPORATION
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3626387
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
3209, South Building
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Building 3, No. 39 Hulan
CY2023 dei City Area Code
CityAreaCode
186
CY2023 dei Local Phone Number
LocalPhoneNumber
21601569
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
West Road, Boashan District
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Shanghai
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
189120068 shares
CY2023 dei Auditor Firm
AuditorFirmId
2851
CY2023 dei Auditor Name
AuditorName
KCCW Accountancy Corp.
CY2023 dei Auditor Location
AuditorLocation
Diamond Bar, California
CY2023Q4 us-gaap Cash
Cash
0 usd
CY2022Q4 us-gaap Assets
Assets
0 usd
CY2022Q4 ybcn Due To Related Party Current
DueToRelatedPartyCurrent
42674 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44642 usd
CY2022Q4 us-gaap Liabilities
Liabilities
44642 usd
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189120068 shares
CY2022Q4 ybcn Common Stock To Be Issued
CommonStockToBeIssued
2282 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
62017 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
82046 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
62017 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
82046 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-62017 usd
CY2023 us-gaap Interest Expense
InterestExpense
0 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62017 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-96213 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-62017 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-96213 usd
CY2023 ybcn Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2022 ybcn Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2023 ybcn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
189120068 shares
CY2022 ybcn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
171220569 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-518488 usd
CY2022 ybcn Correction Of An Error
CorrectionOfAnError
0 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
53551 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
516508 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-96213 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-44642 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-62017 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-106659 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-62017 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-96213 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5354 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-463 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
0 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
14167 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
56663 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
28958 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53551 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53551 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53551 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
516508 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There are no financial instruments that potentially subject the Company to the concentration of credit risk. The Company has not experienced losses and management believes the Company is not exposed to significant credit risks.</p>
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3675708 usd
CY2023Q4 ybcn Working Capital Deficit
WorkingCapitalDeficit
106659 usd
CY2023 us-gaap Interest Expense
InterestExpense
0 usd
CY2022 us-gaap Interest Expense
InterestExpense
14167 usd
CY2022Q3 us-gaap Convertible Debt
ConvertibleDebt
150000 usd
CY2022Q3 us-gaap Convertible Debt
ConvertibleDebt
100000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
516508 usd
CY2009Q3 ybcn Investor Relations Agreement Description
InvestorRelationsAgreementDescription
Pursuant to such agreement, the Company agreed to pay a fee of $1,000 per month for a period of six months beginning on August 1, 2009 and ending January 1, 2010. The Company should have issued 75,000 shares within 7 days of signing the agreement. Any payments over 45 days would be subject to a penalty fee of 10% per week
CY2009Q3 ybcn Penalty Fees
PenaltyFees
0.10 pure
CY2010Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
75000 shares
CY2009Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 usd
CY2010Q1 ybcn Additional Shares Issued
AdditionalSharesIssued
75000 shares
CY2023Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
2282 usd
CY2023 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
effect a 1-for-20 reverse stock split
CY2022 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
53551000 shares
CY2022Q4 us-gaap Share Price
SharePrice
0.001
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189120068 shares
CY2023 us-gaap Sale Of Stock Percentage Of Ownership Before Transaction
SaleOfStockPercentageOfOwnershipBeforeTransaction
0.21 pure
CY2023 ybcn Change In Deferred Tax Asset Valuation Allowance
ChangeInDeferredTaxAssetValuationAllowance
0.21 pure
CY2022 us-gaap Sale Of Stock Percentage Of Ownership Before Transaction
SaleOfStockPercentageOfOwnershipBeforeTransaction
0.21 pure
CY2022 ybcn Change In Deferred Tax Asset Valuation Allowance
ChangeInDeferredTaxAssetValuationAllowance
0.21 pure
CY2023 ybcn Provision For Income Taxes
ProvisionForIncomeTaxes
0 pure
CY2022 ybcn Provision For Income Taxes
ProvisionForIncomeTaxes
0 pure

Files In Submission

Name View Source Status
0001477932-24-002091-index-headers.html Edgar Link pending
0001477932-24-002091-index.html Edgar Link pending
0001477932-24-002091.txt Edgar Link pending
0001477932-24-002091-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ybcn-20231231.xsd Edgar Link pending
ybcn_10k.htm Edgar Link pending
ybcn_ex311.htm Edgar Link pending
ybcn_ex321.htm Edgar Link pending
ybcn-20231231_def.xml Edgar Link unprocessable
ybcn-20231231_lab.xml Edgar Link unprocessable
ybcn-20231231_pre.xml Edgar Link unprocessable
ybcn_10k_htm.xml Edgar Link completed
ybcn-20231231_cal.xml Edgar Link unprocessable